Comparative analysis between untreated CLL-B-cells and those incubated with EVs from patient-derived NLCs revealed a significant increase in the levels of IGFBP-2 and CD40 proteins following EVs treatment. This evidence concerns the gene CD40 and B-cell chronic lymphocytic leukemia.